H5N1 Human Antibody Discovered By Dutch Biotech
September 14th, 2007 by 
Barry - Admin BioPharmArena
Researchers from Dutch biotech company Crucell NV, with headquarters in Leiden, The Netherlands, have discovered a human monoclonal antibody against the deadly strain of H5N1 bird flu.
The company will present findings of pre-clinical studies at the 5th International Bird Flu Summit on September 27th and 28th in Las Vegas, Nevada, US.
Crucell Chief Scientific Officer, Dr Jaap Goudsmit said:
“Using phage display technology a set of human monoclonal antibodies active against a broad range of distinct H5N1 strains was developed.”
The company will show evidence that the newly manufactured antibodies can prevent and cure infection by H5N1 virus in mice.
Scientists at Crucell produced the antibodies using the company’s new PER.C6 cell based vaccine production technology and tested their biophysical and immunological properties.
Posted in News, Research and Development | 
No Comments »